Autophagy and beyond: Unraveling the complexity of UNC-51-like kinase 1 (ULK1) from biological functions to therapeutic implications.
10.1016/j.apsb.2022.06.004
- Author:
Ling ZOU
1
;
Minru LIAO
2
;
Yongqi ZHEN
2
;
Shiou ZHU
2
;
Xiya CHEN
1
;
Jin ZHANG
1
;
Yue HAO
1
;
Bo LIU
2
Author Information
1. School of Pharmaceutical Sciences, Health Science Center, Shenzhen University, Shenzhen 518060, China.
2. State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, Chengdu 610041, China.
- Publication Type:Review
- Keywords:
Autophagy;
Biological function;
Human diseases;
Non-autophagy;
Small-molecule drug;
ULK1-targeted therapy;
UNC-51-like kinase 1 (ULK1)
- From:
Acta Pharmaceutica Sinica B
2022;12(10):3743-3782
- CountryChina
- Language:English
-
Abstract:
UNC-51-like kinase 1 (ULK1), as a serine/threonine kinase, is an autophagic initiator in mammals and a homologous protein of autophagy related protein (Atg) 1 in yeast and of UNC-51 in Caenorhabditis elegans. ULK1 is well-known for autophagy activation, which is evolutionarily conserved in protein transport and indispensable to maintain cell homeostasis. As the direct target of energy and nutrition-sensing kinase, ULK1 may contribute to the distribution and utilization of cellular resources in response to metabolism and is closely associated with multiple pathophysiological processes. Moreover, ULK1 has been widely reported to play a crucial role in human diseases, including cancer, neurodegenerative diseases, cardiovascular disease, and infections, and subsequently targeted small-molecule inhibitors or activators are also demonstrated. Interestingly, the non-autophagy function of ULK1 has been emerging, indicating that non-autophagy-relevant ULK1 signaling network is also linked with diseases under some specific contexts. Therefore, in this review, we summarized the structure and functions of ULK1 as an autophagic initiator, with a focus on some new approaches, and further elucidated the key roles of ULK1 in autophagy and non-autophagy. Additionally, we also discussed the relationships between ULK1 and human diseases, as well as illustrated a rapid progress for better understanding of the discovery of more candidate small-molecule drugs targeting ULK1, which will provide a clue on novel ULK1-targeted therapeutics in the future.
